What Aventine Consulting does

Aventine Consulting LLC, founded in 2008 and headquartered in Marblehead, Massachusetts, is a specialized medical communications consultancy focused on US market access and reimbursement support for the pharmaceutical and biotechnology industries. The firm develops value dossiers (also called formulary submission dossiers or AMCP dossiers) that compile clinical and economic evidence to demonstrate product value to US payers for formulary inclusion and reimbursement. Its core service lines include US value dossiers compliant with AMCP format, preapproval information exchange (PIE) materials for unapproved agents consistent with 2018 FDA guidance, Global Value Dossiers (GVDs) for international submissions, US-based economic models and budget impact analyses, and medical communications support (standard response letters, product monographs, slide decks). The team is composed of highly accomplished PharmDs with over 30 years of combined managed care and clinical pharmacy experience, and the firm has developed more than 250 dossiers across 8 therapeutic areas including oncology, inflammatory and inherited disease, neurology, women's health, infectious disease, and biotechnology products such as CAR-T therapies and biosimilars.

The business operates on a project-based professional services model with pricing not publicly disclosed and direct B2B engagement with pharmaceutical, biotechnology, and medical device companies. Customers are enterprise pharma and biotech clients seeking US payer engagement, with horizontal segmentation across multiple therapeutic areas rather than vertical specialization. In late 2023, Aventine was wholly acquired by Prime Global, a healthcare communications company with over 400 multidisciplinary experts across offices in New York, San Diego, London, and the UK. Post-acquisition, Aventine operates as Prime Aventine within Prime's Evidence & Access capability, gaining access to broader HEOR, real-world evidence, value strategy, brand, and patient insights capabilities while retaining its US dossier and payer communications focus. Aventine's go-to-market relies on direct enterprise sales, professional organization engagement (AMCP, ISPOR), and reputation-driven referrals, with no public customer logos disclosed. The standalone Aventine team is small (1-10 employees), reflecting its specialist boutique positioning within the larger Prime Global network.

Name

Aventine Consulting

Legal name

Aventine Consulting LLC

Website

https://aventine-consulting.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Aventine Consulting is a US-based medical communications consultancy that develops AMCP value dossiers, preapproval information exchange materials, global value dossiers, and economic models to help pharmaceutical and biotechnology companies demonstrate product value to payers and secure formulary reimbursement.

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Access & Reimbursement Consulting

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618), Other Scientific and Technical Consulting Services (54169), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Value Dossier & Evidence Generation (AMCP/Global Value Dossier) (HLAIAKAC)

akta.pro secondary industries

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN), Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), International Reference Pricing (IRP) & External Price Benchmarking (HLAIAKAF)

Keywords

• Market access consulting
• AMCP dossier development
• Medical communications services
• Pharmacoeconomic modeling
• Reimbursement strategy

Headquarters

HQ city

Marblehead

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Medical Communications Consulting Services: Professional consulting services for pharmaceutical and biotech companies including development of AMCP dossiers, value dossiers, economic models, and medical communications materials. Revenue generated through project-based engagements with pharma clients requiring market access and reimbursement support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Aventine Consulting provides medical communications and market access services for pharmaceutical and biotechnology companies, including the development of US value dossiers (AMCP-formatted formulary submission dossiers), preapproval information exchange (PIE) dossiers, global value dossiers for ex-US markets, US-based economic models and budget impact analyses, and medical communications materials such as standard response letters, product monographs, and slide decks. Services are designed to scientifically demonstrate product value to US payers for formulary acceptance and optimal reimbursement.

Product overview

Prime Aventine (formerly Aventine Consulting) is a medical communications team specializing in US market access and reimbursement services. The core offering consists of Value Dossiers (US formulary submission dossiers compliant with AMCP format) and Medical Communications Support Services (including standard response letters, product monographs, and slide decks). These offerings include both Approved Product Dossiers for FDA-approved products and Preapproval Dossiers for unapproved agents under PIE guidelines. The company also provides Global Value Dossiers for international market access support. The company operates as part of Prime's Evidence & Access capability, delivering integrated services alongside Prime Access and Prime HCD.

Differentiator

Problem solved

Functional benefit

Products and services

• Value Dossiers (AMCP Dossiers) US value dossiers (also called formulary submission dossiers or AMCP dossiers) that compile clinical and economic data to present evidence-based value stories for pharmaceutical products to US payers for formulary inclusion and reimbursement.
• Preapproval Information Exchange (PIE) Dossiers Preapproval information exchange dossiers developed for unapproved agents or unapproved uses to help payers plan for budget cycles in advance of anticipated US approvals.
• Global Value Dossiers (GVD) Core global value dossiers developed to support client affiliates' needs for reimbursement policy decisions, health technology assessments, formulary reviews, and payer educational needs across international markets including Canada, UK, EU, Australia, and Latin America.
• Medical Communications Support Services Scientifically accurate, well-referenced, and fair-balanced medical communication materials including standard response letters, product monographs, and slide decks developed for healthcare professional and US payer audiences.
• US-Based Economic Models and Budget Impact Analyses US-based economic models and budget impact analyses developed for pharmaceutical products to support payer reimbursement decisions and formulary evaluations.

Quantifiable outcome

• Developed 250+ value dossiers over the past decade
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Prime (Prime Global People)coreStrategic or Co-development Partner · 1 January 2023Aventine Consulting was wholly acquired by Prime Global in late 2023. Aventine is now part of Prime's expanding Evidence & Access capability, working alongside Prime Access and Prime HCD to deliver integrated global support. The partnership expands Aventine's 15-year excellence in US dossier and payer communications to include the full spectrum of health economics, market access, value communications, and evidence services.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Xcenda: Part of Cencora (formerly AmerisourceBergen), Xcenda is a leading health economics, outcomes research, and market access consultancy that develops AMCP-formatted dossiers, GVDs, and payer communication materials for pharma and biotech clients — directly overlapping Aventine's core offering.
• Avalere Health: Avalere Health is a strategic advisory and market access consultancy offering payer evidence generation, value dossiers, and policy advisory for pharma and biotech — directly comparable to Aventine's US market access dossier practice.
• Precision Value & Health (formerly Precision for Value): Precision Value & Health provides market access, HEOR, and value communication services including AMCP dossier development for pharma manufacturers, competing head-to-head with Aventine on US payer-focused evidence generation.
• Putnam Associates: Putnam Associates is a specialized strategy and evidence consultancy serving biopharma with market access, pricing, and HEOR services including dossier and payer evidence development — closely comparable in scale and specialization to Aventine.
• Evidera: Evidera (formerly part of PPD, now within Elevance/HealthCore ecosystem) provides HEOR, market access, value communication, and dossier development services for pharmaceutical manufacturers globally, competing directly with Aventine on AMCP, GVD, and economic modeling engagements.

Broad incumbents

• Decision Resources Group (DRG): DRG, part of Clarivate, provides market access insights, value dossiers, and global reimbursement evidence for pharma manufacturers — comparable offering to Aventine's value dossier and Global Value Dossier services at greater scale and with proprietary data assets.
• Charles River Associates (CRA): CRA's Life Sciences practice provides HEOR, market access, and pricing/reimbursement advisory including dossier and evidence generation services as part of a broader management consulting portfolio — overlaps with Aventine but at significantly larger scale and broader scope.
• Analysis Group: Analysis Group's Health Economics and Outcomes Research practice provides HEOR, economic modeling, and payer evidence support for pharma — overlapping with Aventine's economic modeling and value dossier work as part of a much broader economics and litigation consulting portfolio.
• IQVIA (Real World Evidence / Market Access): IQVIA offers integrated HEOR, market access, value communication, and real-world evidence services including dossier development for global pharma — a broad incumbent whose market access practice competes with Aventine on large multi-region dossiers.

Emerging players

• Covia Health Solutions: Covia Health Solutions is a specialized market access consultancy offering AMCP dossier development, payer communications, and value evidence services to pharma and biotech — a more focused emerging competitor comparable to Aventine in size and specialization.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aventine-consulting-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aventine Consulting